48-week outcomes were the key secondary [3]
doi: 10.1016/j.neuroscience.2015.06.054 Summary Keywords Parkinsons disease, diabetes, glucagon-like peptide 1, insulin, energy metabolism, neuroprotection Citation Lv D, Feng P, Guan X, Liu Z, Li D, Xue C, Bai B and Hlscher C (2024) Neuroprotective effects of GLP-1 class drugs in Parkinsons disease
Archives of Medical Science : AMS 8(5):924930
Dimitrina Vizinas, DO, takes into account your overall health, wellness goals, and lifestyle when determining the best treatment plan for you
Cost and value assessment At 12 for a months supply (30 patches), Kind Patches initially appear more affordable than prescription alternatives